Featured Article
Nutraceuticals May Benefit Patients Who Are Statin Intolerant
Nutraceuticals may offer a solution to patients who cannot tolerate statins because of severe muscle pain.
Latest Features
Nutraceuticals May Benefit Patients Who Are Statin Intolerant
Nutraceuticals may offer a solution to patients who cannot tolerate statins because of severe muscle pain.
Breathing New Life Into COPD and Asthma Therapy With Statins
Statins have anti-inflammatory and anti-oxidative effects, which could reduce exacerbations of both asthma and chronic obstructive pulmonary disease.
PCSK9 Inhibitor Alirocumab Associated With 75% Reduction in Apheresis
Among patients with heterozygous familial hypercholesterolemia, alirocumab was associated with a 75% reduction in lipoprotein apheresis compared with placebo.
Statins Limit Vaccine Efficacy of Influenza Strain
Statin use modified vaccine effectiveness and influenza risk for A(H3N2) infection but not for A(H1N1).
Higher Vitamin D Levels May Related to Higher Total Cholesterol, HDL-C
Vitamin D may influence cardiovascular disease risk via its effect on lipid levels.
Considering Cardiovascular Risks of Antidiabetic Drugs
A review of current antidiabetic drug treatments available and their individual cardiovascular risk profiles.
PCSK9 Inhibitors: Breakthrough in LDL-C Reduction, But Comes at a Cost
PCSK9 inhibitors may offer hope to patients with familial hypercholesterolemia who cannot tolerate or achieve goal LDL-C levels with statins.
LATEST NEWS
Coenzyme Q10 Supplementation May Reduce Statin-Induced Myopathy
Supplementation with coenzyme Q10 may be an effective approach for managing statin-induced myopathy.
Triglyceride-Lowering Alleles Associated With Reduced Coronary Artery Disease Risk
Triglyceride-lowering variants in the lipoprotein lipase pathway are independently associated with protection from coronary artery disease and type 2 diabetes.
Shared Financial Incentives Cost-Effective for Controlling LDL-C Levels
Implementing shared financial incentives between physicians and patients is a cost-effective intervention strategy for controlling LDL-C levels among high-risk patients.
FDA to Review Praluent as Potential Treatment for MACE Risk Reduction
The sBLA is supported by data from the Phase 3 ODYSSEY OUTCOMES trial which included 18,924 patients who had experienced an acute coronary syndrome (ACS) in the previous 12 months.
Familial Hypercholesterolemia Benefits From Genetic Screening
Genetic screening for familial hypercholesterolemia would improve the likelihood of a definitive diagnosis and may help clinicians choose the appropriate therapy for patients.
FDA Issues CRL Rejecting Waylivra Approval for Familial Chylomicronemia Syndrome
"We are extremely disappointed with the FDA's decision. We continue to feel strongly that Waylivra demonstrates a favorable benefit/risk profile in people with FCS," said Akcea CEO, Paula Soteropoulos.
Praluent Labeling Updated With Dosing for HeFH Patients Undergoing LDL Apheresis
The dosing recommendation was based on data from a double-blind, placebo-controlled study conducted in 62 patients with HeFH undergoing LDL apheresis.
Nutraceuticals May Benefit Patients Who Are Statin Intolerant
Nutraceuticals may offer a solution to patients who cannot tolerate statins because of severe muscle pain.
Vitamin D Independently, Inversely Tied to Cholesterol in Children
Gene variants did not modify the associations of 25(OH)D with lipids.
Patient Connectivity Benefits Familial Chylomicronemia Syndrome
Patients with familial chylomicronemia syndrome who were actively connected were also 3 times as likely to report "high" or "extremely high" motivation in managing their own health.
The Cardiology Advisor Articles
- Class 1 Device Recall: Endologix AFX Device Recalled Due to Type III Endoleaks
- Harvard: Fraudulent Data Found in Publications of Heart Researcher
- Traumatic Life Events May Increase Risk for Atrial Fibrillation in Older Women
- No Differences Between Bivalirudin, UFH Post-PCI After Ticagrelor Pretreatment
- Rivaroxaban Approved to Reduce Risk of Major Cardiovascular Events in CAD, PAD
- Coenzyme Q10 Supplementation May Reduce Statin-Induced Myopathy
- Long-Term Exposure to Elevated BP Associated With AS and AR
- Risk Factors for Atherosclerotic Cardiovascular Disease in the South Asian Population
- Takotsubo Syndrome Associated With Substantial Morbidity, Mortality
- Bariatric Surgery Reduces Macrovascular Complications in Obesity, T2D
- Metformin May Improve Vascular Health in Adolescents With Type 1 Diabetes
- Improved Cardiovascular Event Reporting Needed in Leukemia Clinical Trials
- Psoriasis Associated With Clinical Signs of Accelerated Atherosclerosis
- Can Dermatoscope Magnets Be Used With CV Implanted Electronic Devices?
- The Striking Effects of Diversity in Health Care: Improving Patient Outcomes